FDA Import Refusal 1FX-9382363-2/10002/1 — Glaxo Wellcome S.A.
The FDA refused shipment 1FX-9382363-2/10002/1 from Glaxo Wellcome S.A. (Spain) on Nov 3, 2026. The refused product falls under Drugs and Biologics — BRONCHODILATOR N.E.C.. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 3, 2026
- Country
- Spain
- Product Category
- Drugs and Biologics
- Product Code
- 63BDY99 BRONCHODILATOR N.E.C.
- Charges
- 118,3280